Skip to main content
< Back
Lisbon Addictions 2024 logo
  • About
    • About the conference
    • Organisers & Partners
    • Registration
    • App
    • Podcast
    • Early Career Researchers
    • Call for abstracts
    • Guidelines
    • Latest updates
    • Press room
    • Venue
  • Programme
    • Full programme
    • Programme outline
  • Tracks
  • Speakers
    • All speakers
    • Keynote speakers
  • Side events
  • Subscribe

Frost
Michael

  • President/Medical Director
  • Frost Medical Group
  • United States

In Programme

  • October, 23 09:00 to 18:20
  • October, 23 16:50 to 18:20
View Hours & Dates

Hours & Dates

Wednesday, October 23

09:00

  • e-poster

    Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine

    09:00 to 18:20
    Digital kiosks
    Michael Frost

Wednesday, October 23

16:50

  • Short communication

    Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder

    16:50 to 18:20
    Room 1.06
    Michael Frost
View all speakers

Lisbon Addictions, European Conference on Addictive Behaviours and Dependencies.

Quick links

  • Policy & disclaimer
  • Diversity statement
  • Newsletter
  • Twitter
  • Facebook
  • Mail
  • LinkedIn

© 2024 Lisbon Addictions 2024 All rights reserved.

MENU
Back

Lisbon Addictions 2024

  • My profile
  • Notifications
  • My favourites
  • Scan contacts
  • My contacts
  • Settings